JAKARTA, Indonesia – Testsealabs (Hangzhou Testsea Biotechnology Co., Ltd.), a trusted global provider of professional in vitro diagnostic solutions, has successfully obtained official Indonesian medical device registration for four key rapid diagnostic products. These high-quality, CE‑marked test kits are now legally available across Indonesia and have earned strong recognition and positive feedback from hospitals, clinics, laboratories and healthcare professionals nationwide.
The fully registered and well‑received product portfolio includes:
- TESTSEALABS® Influenza Ag A/B Test Cassette
- TESTSEALABS® Dengue IgG/IgM + NS1 Antigen Test Cassette
- TESTSEALABS® Malaria Ag P.f/P.v Tri-line Test Cassette
- TESTSEALABS® Typhoid IgG/IgM Test Cassette
All tests adopt advanced immunochromatographic technology, providing fast, clear and stable results within 15 minutes to support early screening, differential diagnosis and timely clinical intervention for major local infectious diseases.
Product Highlights & Clinical Value
TESTSEALABS® Influenza Ag A/B Test Cassette
Professional rapid test for qualitative detection of influenza A and influenza B virus antigens in nasopharyngeal swab specimens. Designed for high accuracy and reliable performance, effectively supporting influenza screening and respiratory infection management.
TESTSEALABS® Dengue IgG/IgM + NS1 Antigen Test Cassette
Comprehensive dengue test that detects NS1 antigen and IgG/IgM antibodies in whole blood, serum or plasma. Supports early diagnosis and retrospective identification of dengue infection, with strong anti‑interference and stable performance in various clinical conditions.
TESTSEALABS® Malaria Ag P.f/P.v Tri-line Test Cassette
Specialized rapid test for qualitative detection of key malaria markers in whole blood, enabling effective differential identification of common malaria types. Simple to use and suitable for field and clinical rapid testing.
TESTSEALABS® Typhoid IgG/IgM Test Cassette
Reliable test for qualitative detection of typhoid IgG and IgM antibodies in whole blood, serum or plasma. Supports early and follow-up diagnosis of typhoid infection, delivering consistent performance for daily clinical use.
All four products feature easy operation, low equipment requirements and clear visual reading, making them highly suitable for point‑of‑care testing (POCT) in clinics, community health centers and field disease surveillance. They have been widely used in infectious disease screening, epidemic monitoring and routine clinical diagnosis across Indonesia.
With reliable quality, stable performance and user‑friendly design, Testsealabs rapid test kits have become a preferred choice for local healthcare providers and received consistent positive reviews for improving diagnostic efficiency and supporting public health responses.
“We are proud that our high‑quality diagnostic solutions are trusted and recognized in the Indonesian market,” said a spokesperson for Testsealabs. “These official registrations and market feedback validate our long‑term focus on product quality, clinical value and global regulatory compliance. We will continue to provide safe, effective and accessible diagnostic tools to support Indonesia’s public health development and disease prevention capabilities.”
About Testsealabs
Founded in 2015 with the pursuit “serving society, health world”, Testsealabs focuses on the R&D, production, sales and service of in vitro diagnostic products and veterinary products. The company has built advanced technology platforms including immunological detection, molecular biology detection, protein core test and biological raw materials.
Testsealabs offers a comprehensive product range covering infectious diseases, cardiovascular diseases, inflammation, tumors, pregnancy, drug abuse and more. Its products are widely used in critical care diagnosis, maternal and child health, drug detection and alcohol testing, and are sold to more than 100 countries and regions worldwide.
Adhering to the principles of quality first, customer first and credit‑based, Testsealabs sincerely cooperates with global partners to create win-win value and promote better health for all.
Post time: Apr-15-2026